"Fatigue" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
| Descriptor ID |
D005221
|
| MeSH Number(s) |
C23.888.369
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fatigue".
Below are MeSH descriptors whose meaning is more specific than "Fatigue".
This graph shows the total number of publications written about "Fatigue" by people in this website by year, and whether "Fatigue" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 3 | 1 | 4 |
| 2007 | 3 | 3 | 6 |
| 2008 | 1 | 3 | 4 |
| 2009 | 3 | 3 | 6 |
| 2010 | 2 | 4 | 6 |
| 2011 | 3 | 4 | 7 |
| 2012 | 1 | 4 | 5 |
| 2013 | 1 | 4 | 5 |
| 2014 | 0 | 6 | 6 |
| 2015 | 4 | 4 | 8 |
| 2016 | 0 | 4 | 4 |
| 2017 | 2 | 4 | 6 |
| 2018 | 3 | 4 | 7 |
| 2019 | 0 | 5 | 5 |
| 2020 | 1 | 4 | 5 |
| 2021 | 0 | 4 | 4 |
| 2022 | 1 | 8 | 9 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 4 | 5 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fatigue" by people in Profiles.
-
Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study. Inflamm Bowel Dis. 2025 Feb 06; 31(2):432-441.
-
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med. 2025 Feb 13; 392(7):653-665.
-
Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC. Immunohorizons. 2024 08 01; 8(8):577-585.
-
Assessing the longevity of attribute framing in attenuating the nocebo effect to brand and generic medication. Appl Psychol Health Well Being. 2024 Nov; 16(4):2026-2047.
-
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-up. PLoS One. 2024; 19(4):e0297481.
-
Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias. Mov Disord Clin Pract. 2024 May; 11(5):496-503.
-
An observational, patient-reported outcome study of sleep quality and depression among individuals with overactive bladder syndrome. Neurourol Urodyn. 2024 Feb; 43(2):437-448.
-
Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection. Brain Behav Immun. 2023 11; 114:462-474.
-
Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohort. PLoS One. 2023; 18(9):e0291259.
-
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 06 13; 329(22):1934-1946.